Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale

Himanshu K
,
Riya Mukherjee
ORCID logo ,
Jasmina Vidic
ORCID logo ,
Elcio Leal
ORCID logo ,
Antonio Charlys da Costa
ORCID logo ,
Carlos Prudencio
,
V. Samuel Raj
,
Ramendra Pandey
* ORCID logo ,
Chung-Ming Chang
ORCID logo
Version 1 : Received: 19 May 2023 / Approved: 22 May 2023 / Online: 22 May 2023 (10:55:31 CEST)

A peer-reviewed article of this Preprint also exists.

Himanshu; Mukherjee, R.; Vidic, J.; Leal, E.; da Costa, A.C.; Prudencio, C.R.; Raj, V.S.; Chang, C.-M.; Pandey, R.P. Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale. Biomolecules 2023, 13, 1182. Himanshu; Mukherjee, R.; Vidic, J.; Leal, E.; da Costa, A.C.; Prudencio, C.R.; Raj, V.S.; Chang, C.-M.; Pandey, R.P. Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale. Biomolecules 2023, 13, 1182.

Abstract

Antimicrobial resistance (AMR) is a growing public health concern worldwide, and it poses a significant threat to human, animal, and environmental health. The overuse and misuse of antibiotics have contributed significantly to the emergence and spread of antimicrobial resistance, which may lead to significant economic consequences like reduced productivity and increased healthcare costs. Nanotechnology offers a promising platform for addressing this challenge. Nanoparticles have unique properties that make them highly effective in combating bacterial infections by inhibiting the growth and survival of multidrug-resistant bacteria in three areas of health: human, animal, and environmental. To conduct an economic evaluation of surveillance in this context, it is crucial to have a comprehension of the connections to be addressed by several nations by implementing national action policies based on the One Health strategy. This review provides an overview of the progress made thus far and presents potential future directions to optimize the impact of nanobiotics on AMR.

Keywords

Antibiotic; antimicrobial resistance (AMR); One-Health; economic; nanotechnology; policy

Subject

Biology and Life Sciences, Biology and Biotechnology

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download PDF

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0
Get PDF Cite Share 0
Bookmark BibSonomy Mendeley Reddit Delicious
×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.